Does the choice of β-blocker affect outcome in chronic heart failure?

Bal, Sharon K.
November 2003
CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1188
Academic Journal
Presents a study which compared clinical outcomes of treatments with carvedilol and metoprolol β-blockers in patients with chronic heart failure. Absolute risk reduction in mortality over 5 years in the carvedilol group; Mean reduction in heart rate in the carvedilol and metoprolol group; Implications for the treatment of chronic heart failure.


Related Articles

  • Carvedilol or Metoprolol for Chronic Heart Failure? Walling, Anne D. // American Family Physician;2/15/2004, Vol. 69 Issue 4, p985 

    Discusses research being done on the efficacy of carvedilol and metoprolol in the treatment of patients with mild to severe chronic heart failure. Reference to a study by P.A. Poole-Wilson et al published in the July 5, 2003 issue of the journal "Lancet"; Comparison between the baseline...

  • A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly.  // BMC Medical Research Methodology;2011, Vol. 11 Issue 1, p106 

    The article presents a self-controlled case study on the use of beta blockers in improving the treatment outcomes of patients suffering from heart failure and their role in reducing hospitalization of patients. It is mentioned that the database of the Department of Veterans' Affair of Australia...

  • PII-1. Cheang, K. I.; Vardeny, O.; Zebrack, J. S.; Munger, M. A.; Gilbert, E. M. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP35 

    Background: β2-adrenergic receptor (ADRB2) polymorphisms affect β2-mediated glucose production by terbutaline. Whether beta-blockers' effects on β2-mediated glucose production are affected by ADRB2 polymorphisms is unknown. This study determines the effect of ADRB2 Arg16Gly and Glu27Gln...

  • Selective versus nonselective β-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization. Al-Hesayen, Abdul; Azevedo, Eduardo R.; Floras, John S.; Hollingshead, Shauna; Lopaschuk, Gary D.; Parker, John D. // European Journal of Heart Failure;Jun2005, Vol. 7 Issue 4, p618 

    Background: Non-selective and selective β-blockers have been shown to improve outcomes in chronic heart failure (CHF). Recent data suggests the non-selective β-blockers have a more favourable effect on outcomes than β1-selective agents. We sought to examine the differential effects of...

  • Beta-blockers for heart failure: Why you should use them more. Ong, Hean T.; Kow, Fei P. // Journal of Family Practice;Aug2011, Vol. 60 Issue 8, p472 

    The article focuses on the use of beta-blockers such as bisoprolol, carvedilol and metoprolol succinate to reduce morbidity and mortality in systolic heart failure patients. It states that the Carvedilol or Metoprolol European Trial (COMET) found the carvedilol is better at extending survival...

  • A comparison of beta-blockers in heart failure. Pinkowish, Mary Desmond // Patient Care for the Nurse Practitioner;Oct2000, Vol. 3 Issue 10, p16 

    Features a comparative study on the long-term effects of metoprolol and carvedilol, beta blockers, in patients with heart failure. Aims of the study; Study design; Findings of the study.

  • Nebivolol: A unique drug in acute and chronic renal disorders. Amiri, Fateme Shamekhi // Indian Journal of Pharmacology;Jul/Aug2015, Vol. 47 Issue 4, p462 

    A letter to the editor is presented in response to the article "Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta-blockers?" in the 2014 issue.

  • Effect of Carvedilol on Survival in Severe Chronic Heart Failure. Packer, Milton; Coats, Andrew J.S.; Fowler, Michael B.; Katus, Hugo A.; Krum, Henry; Mohacsi, Paul; Rouleau, Jean L.; Tendera, Michal; Castaigne, Alain; Roecker, Ellen B.; Schultz, Melissa K.; Staiger, Christoph; Curtin, Ellen L.; DeMets, David L. // New England Journal of Medicine;05/31/2001, Vol. 344 Issue 22, p1651 

    Background: Beta-blocking agents reduce the risk of hospitalization and death in patients with mild-to-moderate heart failure, but little is known about their effects in severe heart failure. Methods: We evaluated 2289 patients who had symptoms of heart failure at rest or on minimal exertion,...

  • Expanding Indications for Beta-Blockers in Heart Failure. Braunwald, Eugene // New England Journal of Medicine;05/31/2001, Vol. 344 Issue 22, p1711 

    Editorial. Discusses the use of beta-blockers to treat heart failure. Two studies in this issue which report on the effects of beta-blockade and which appear to have come to opposite conclusions; Prudence of remaining alert to racial differences in the response to beta-blockers in future...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics